Literature DB >> 12748112

Intrathecal injection of contrast medium to prevent polymethylmethacrylate leakage during percutaneous vertebroplasty.

John S Sarzier1, Avery J Evans.   

Abstract

The major technical drawback of percutaneous vertebroplasty is the potential for neural compromise from leakage of polymethylmethaorylate into epidural or perivertebral veins. We have combined the procedure of intrathecal injection of contrast medium with vertebroplasty to better delineate spinal canal encroachment during injection when the posterior vertebral wall is compromised by myeloma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748112      PMCID: PMC7975768     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

1.  Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results.

Authors:  H Deramond; C Depriester; P Galibert; D Le Gars
Journal:  Radiol Clin North Am       Date:  1998-05       Impact factor: 2.303

2.  [Percutaneous vertebral surgery. Technics and indications].

Authors:  J Chiras; C Depriester; A Weill; M T Sola-Martinez; H Deramond
Journal:  J Neuroradiol       Date:  1997-06       Impact factor: 3.447

3.  Percutaneous injection of orthopedic cement in metastatic vertebral lesions.

Authors:  P Kaemmerlen; P Thiesse; P Jonas; C L Bérard; J Duquesnel; Y Bascoulergue; C Lapras
Journal:  N Engl J Med       Date:  1989-07-13       Impact factor: 91.245

4.  Percutaneous vertebroplasty guided by a combination of CT and fluoroscopy.

Authors:  A Gangi; B A Kastler; J L Dietemann
Journal:  AJNR Am J Neuroradiol       Date:  1994-01       Impact factor: 3.825

5.  [Percutaneous acrylic vertebroplasty as a treatment of vertebral angioma as well as painful and debilitating diseases].

Authors:  P Galibert; H Déramond
Journal:  Chirurgie       Date:  1990

6.  Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up.

Authors:  A Cotten; F Dewatre; B Cortet; R Assaker; D Leblond; B Duquesnoy; P Chastanet; J Clarisse
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

7.  Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement.

Authors:  A Weill; J Chiras; J M Simon; M Rose; T Sola-Martinez; E Enkaoua
Journal:  Radiology       Date:  1996-04       Impact factor: 11.105

  7 in total
  4 in total

1.  Vertebroplasty in the treatment of spine disease.

Authors:  G Ambrosanio; A Lavanga; P Vassallo; R Izzo; A A Diano; M Muto
Journal:  Interv Neuroradiol       Date:  2006-02-10       Impact factor: 1.610

Review 2.  Metastatic spinal lesions: state-of-the-art treatment options and future trends.

Authors:  B A Georgy
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-19       Impact factor: 3.825

Review 3.  Complications of percutaneous vertebroplasty and their prevention.

Authors:  J D Laredo; B Hamze
Journal:  Skeletal Radiol       Date:  2004-06-17       Impact factor: 2.199

4.  Vertebroplasty for osteoporotic fractures with spinal canal compromise.

Authors:  A Hiwatashi; P-L A Westesson
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.